BSE Live
Jan 02, 16:01Prev. Close
41.08
Open Price
41.10
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 02, 15:57Prev. Close
41.11
Open Price
41.11
Bid Price (Qty.)
42.03 (2438)
Offer Price (Qty.)
0.00 (0)
| Key Financial Ratios of Morepen Laboratories (in Rs. Cr.) | Mar 16 | Mar 15 | Mar 14 | Mar 13 | Mar 12 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 0.28 | 0.04 | -0.07 | -0.45 | -0.54 | |
| Diluted EPS (Rs.) | 0.28 | 0.04 | -0.07 | -0.45 | -0.54 | |
| Cash EPS (Rs.) | 1.07 | 0.91 | 0.96 | 0.56 | 0.54 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 4.00 | 3.72 | 3.94 | 4.00 | 4.45 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 4.00 | 3.72 | 3.94 | 4.00 | 4.45 | |
| Revenue from Operations/Share (Rs.) | 10.78 | 8.91 | 8.16 | 7.25 | 6.43 | |
| PBDIT/Share (Rs.) | 1.40 | 1.10 | 1.11 | 0.75 | 0.45 | |
| PBIT/Share (Rs.) | 0.61 | 0.24 | 0.10 | -0.27 | -0.61 | |
| PBT/Share (Rs.) | 0.38 | 0.05 | -0.13 | -0.52 | -0.79 | |
| Net Profit/Share (Rs.) | 0.28 | 0.05 | -0.06 | -0.46 | -0.53 | |
| NP After MI And SOA / Share (Rs.) | 0.28 | 0.05 | -0.06 | -0.46 | -0.53 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 12.93 | 12.38 | 13.66 | 10.37 | 7.05 | |
| PBIT Margin (%) | 5.68 | 2.73 | 1.16 | -3.67 | -9.55 | |
| PBT Margin (%) | 3.51 | 0.56 | -1.53 | -7.24 | -12.30 | |
| Net Profit Margin (%) | 2.63 | 0.53 | -0.74 | -6.29 | -8.16 | |
| NP After MI And SOA Margin (%) | 2.63 | 0.53 | -0.75 | -6.29 | -8.17 | |
| Return on Networth/Equity (%) | 7.08 | 1.27 | -1.56 | -11.38 | -11.78 | |
| Return on Capital Employed (%) | 3.58 | 0.59 | -0.72 | -5.08 | -5.36 | |
| Return on Assets (%) | 2.44 | 0.43 | -0.56 | -4.05 | -4.32 | |
| Total Debt/Equity (X) | 0.24 | 0.38 | 0.43 | 0.53 | 0.57 | |
| Asset Turnover Ratio (%) | 92.62 | 81.93 | 74.94 | 64.39 | 52.89 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 0.94 | 0.90 | 1.11 | 0.89 | 0.85 | |
| Quick Ratio (X) | 0.69 | 0.61 | 0.80 | 0.53 | 0.48 | |
| Inventory Turnover Ratio (X) | 11.51 | 10.80 | 11.02 | 8.80 | 7.48 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Coverage Ratios | ||||||
| Interest Coverage Ratios (%) | 2.62 | 1.26 | 0.43 | -1.03 | -3.47 | |
| Interest Coverage Ratios (Post Tax) (%) | 2.62 | 1.26 | 0.43 | -1.03 | -3.47 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 1,332.03 | 702.97 | 357.93 | 321.24 | 369.40 | |
| EV/Net Operating Revenue (X) | 2.75 | 1.75 | 0.98 | 0.99 | 1.28 | |
| EV/EBITDA (X) | 21.22 | 14.17 | 7.14 | 9.50 | 18.10 | |
| MarketCap/Net Operating Revenue (X) | 2.42 | 1.32 | 0.47 | 0.35 | 0.49 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/BV (X) | 6.50 | 3.15 | 0.97 | 0.63 | 0.70 | |
| Price/Net Operating Revenue | 2.42 | 1.32 | 0.47 | 0.35 | 0.49 | |
| Earnings Yield | 0.01 | 0.00 | -0.02 | -0.18 | -0.17 |
26.11.2025
Morepen Lab Consolidated September 2025 Net Sales at Rs 411.58 crore, down 5.97% Y-o-Y
24.11.2025
Morepen Lab Standalone September 2025 Net Sales at Rs 369.53 crore, down 3.69% Y-o-Y
12.08.2025
Morepen Lab Consolidated June 2025 Net Sales at Rs 425.24 crore, down 6.59% Y-o-Y
07.08.2025
Morepen Lab Standalone June 2025 Net Sales at Rs 391.28 crore, up 1.46% Y-o-Y
26.11.2025
Morepen Lab Consolidated September 2025 Net Sales at Rs 411.58 crore, down 5.97% Y-o-Y
24.11.2025
Morepen Lab Standalone September 2025 Net Sales at Rs 369.53 crore, down 3.69% Y-o-Y
12.08.2025
Morepen Lab Consolidated June 2025 Net Sales at Rs 425.24 crore, down 6.59% Y-o-Y
07.08.2025
Morepen Lab Standalone June 2025 Net Sales at Rs 391.28 crore, up 1.46% Y-o-Y